Zurueck zur Suche

Reporte zur Charge U022732

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

12Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 6 CT 3 OH 1 PA 1

VAERS 2305313

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U022732

mild
Staat
OH
Alter
1,0
Geschlecht
F
Eingang
01.06.2022
Impfdatum
16.05.2022
Beginn
30.05.2022
Tage bis Beginn
14,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Rash Rash erythematous Rash macular

Symptomtext

Patient developed diarrhea and broke out in a rash 16 days after the vaccinations. erythematous macular rash primarily centrally at the time of visit. NO vesicles, petechiae or purpura. No fevers. the rash just starting to show at the ankle but sparing of the palms and soles.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2367834

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U022732

gering
Staat
PA
Alter
1,0
Geschlecht
M
Eingang
13.07.2022
Impfdatum
12.07.2022
Beginn
12.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Wrong product administered

Symptomtext

Medication error- MMRV inadvertently given instead of MMR, resulting in 2 doses of varicella being given on same day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2225580

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U022732

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
11.04.2022
Impfdatum
18.03.2022
Beginn
18.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no other symptoms or other AE reported; doses of VARIVAX were given following temperature excursion; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 18-MAR-2022, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U022732, expiration date: 20-JUL-2023; strength, dose, and route were not reported) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of 7.4 Fahrenheit (F) for a time frame of 10 minutes (on 01-MAR-2022). There were no previous temperature excursion. No other symptoms or other adverse event was reported. This is one of the several cases reported by the same reporter.; Sender's Comments: US-009507513-2203USA010326:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2225114

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U022732

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
09.04.2022
Impfdatum
01.03.2022
Beginn
01.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other symptoms or AE reported; Caller is an office manager who reports four doses of VARIVAX were given following temperature excursion. No other symptoms or other AE reported. No other AE/no PQC. ? Names of vaccines involved (including lot/exp) VARIVAX, lot U022732 e; This spontaneous report was received from an office manager on 29-MAR-2022, concerning a patient of unknown age and gender.There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. In March 2022, the patient was vaccinated with an improperly stored doses of varicella virus vaccine live (oka/merck)(VARIVAX) lot # U022732, expiration date: 20-JUL-2023 for prophylaxis (dose and route of administration were not reported) (Product storage error). The administered dose of the vaccine experienced a temperature excursion of 7.4 Fahrenheit for 10 minutes and 5.4 Fahrenheit for 5 minutes, on 25-MAR-2022. Previous excursion was not reported. The cumulative time frame was reported as 15 minutes. It was unspecified if the data was recorded by a data logger. There was no adverse effect reported. No product quality complaint was involved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2213578

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U022732

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
04.04.2022
Impfdatum
14.03.2022
Beginn
14.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other symptoms or other AE reported; dose of VARIVAX was given following temperature excursion; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapies were not reported. A temperature excursion of varicella virus vaccine live (oka/merck) (VARIVAX) was registered as 7.4 degrees Fahrenheit for 10 minutes on 01-MAR-2022. On 14-MAR-2022, the patient was vaccinated with the improperly storage dose of varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose, route were not provided) with lot # U022732 and expiration date of 20-JUL-2023 for prophylaxis. There was no previous temperature excursion. No other symptoms or other adverse event (AE) reported. This is one of four cases received from the same reporter.; Sender's Comments: US-009507513-2203USA010197: US-009507513-2203USA010326: US-009507513-2203USA010401:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208692

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U022732

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
31.03.2022
Impfdatum
23.03.2022
Beginn
23.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no other symptoms or other AE reported; doses of VARIVAX were given following temperature excursion; This spontaneous report as received from a office manager refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, or concomitant therapies were not provided. A temperature excursion of varicella virus vaccine live (oka/merck)(VARIVAX) was registered as 7.4 ?F for 10 minutes on 01-MAR-2022. On 23-MAR-2022, the patient was vaccinated with the improperly storage dose of varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose, route were not provided) with lot # U022732 and expiration date of 20-JUL-2023 for prophylaxis. There was no previous temperature excursion. No adverse events were reported. This is one of several cases received from the same reporter. ?; Sender's Comments: US-009507513-2203USA010197:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2188816

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U022732

gering
Staat
-
Alter
10,0
Geschlecht
U
Eingang
19.03.2022
Impfdatum
18.01.2022
Beginn
18.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

V ARlVAX underwent a temperature excursion and was then administered; This spontaneous report has been received from a clinic administrator and refers to a 10-year-old patient. The patient's medical history, concurrent conditions, concomitant therapies, and drugs reactions or allergies were not reported. On 18-JAN-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX), 0.5 milliliter, lot U022732 has been verified to be a valid lot number for varicella virus vaccine live (oka/merck) with a n expiration date on 20-JUL-2023, administered as prophylaxis (formulation, strength, frequency, anatomical injection site and route of administration were not provided). Administered dose of vaccine experienced temperature excursion of 12.0 degrees Fahrenheit (F) for 9 hours and 38 minutes. There was previous temperature excursions (9.7 degree Fahrenheit for 2 hours and 41 minutes; 10.8 degree Fahrenheit for 2 hours and 45 minutes; 10.6 degree Fahrenheit for 4 hours and 16 minutes; 11.1 degree Fahrenheit for 3 hours and 14 minutes; 10.9 degree Fahrenheit for 4 hours and 43 minutes; 10.8 degree Fahrenheit for 2 hours and 17 minutes; 18.3 degree Fahrenheit for 2 hours and 36 minutes; 18.7 degree Fahrenheit for 3 hours and 4 minutes; 12.4 degree Fahrenheit for 9 hours and 43 minutes; 17.4 degree Fahrenheit for 24 hours and 00 minutes; 19.9 degree Fahrenheit for 10 hours and 57 minutes. (product storage error). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2202USA006001: US-009507513-2202USA005934:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2173326

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U022732

gering
Staat
MI
Alter
0,5
Geschlecht
M
Eingang
11.03.2022
Impfdatum
11.03.2022
Beginn
11.03.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient was given Varicella vaccine during 6 month well child visit. No adverse events occurred at that time. Physician researched possible adverse events in order to give parents information on what to look for in case of adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2164889

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U022732

gering
Staat
CT
Alter
7,0
Geschlecht
U
Eingang
08.03.2022
Impfdatum
05.02.2022
Beginn
05.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no additional information available or provided; VARlVAX underwent a temperature excursion and was then administered to a patient; This spontaneous report was received from a reporter with an unspecified qualification (reported as "administrator") and refers to 7-year-old patient of an unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 05-FEB-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliter, lot # U022732was confirmed to be valid, expiration date 20-JUL-2023, for prophylaxis (route and site of administration were not reported). The administered dose was exposed to the temperature of 12 degrees Fahrenheit (F) for 9 hours and 38 minutes. There were also previous temperature excursions reported as follows: 9.7 F for 2 hours and 41 minutes; 10.8 F for 2 hours and 45 minutes; 10.6 F for 4 hours and 16 minutes; 11.1 F for 3 hours and 14 minutes; 10.9 F for 4 hours and 43 minutes; 10.8 F for 2 hours and 17 minutes; 18.3 F for 2 hours and 36 minutes; 18.7 F for 3 hours and 4 minutes; 12.4 F for 9 hours and 43 minutes; 17. 4 F for 24 hours and 0 minutes; 19.9 F for 10 hours and 57 minutes. No additional information was available or provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2150589

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U022732

gering
Staat
CT
Alter
3,0
Geschlecht
U
Eingang
01.03.2022
Impfdatum
21.01.2022
Beginn
21.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

underwent a temperature excursion and was then administered to a patient; This spontaneous report has been received from a clinic administrator was received from physician and refers to a 3-year-old patient. The patient's medical history, the patient's concurrent conditions, concomitant therapies, and drugs reactions or allergies were not reported. On 21-JAN-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX), 0.5 milliliter, lot #U022732, expiration date: 20-JUL-2023, administered as prophylaxis (formulation, strength, and route of administration were not provided). There was no adverse effect. The stored temperature was 12 degrees Fahrenheit (F) the time frame was 9 hours and 38 minutes. There was previous temperature excursion (9.7 degree Fahrenheit for 2 hours and 41 minutes; 10.8 degree Fahrenheit for 2 hours and 45 minutes; 10.6 degree Fahrenheit for 4 hours and 16 minutes; 11.1 degree Fahrenheit for 3 hours and 14 minutes; 10.9 degree Fahrenheit for 4 hours and 43 minutes; 10.8 degree Fahrenheit for 2 hours and 17 minutes; 18.3 degree Fahrenheit for 2 hours and 36 minutes; 18.7 degree Fahrenheit for 3 hours and 4 minutes; 12.4 degree Fahrenheit for 9 hours and 43 minutes; 17.4 degree Fahrenheit for 24 hours and 00 minutes; 19.9 degree Fahrenheit for 10 hours and 57 minutes. (product storage error). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2202USA006001:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2141870

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U022732

gering
Staat
CT
Alter
-
Geschlecht
U
Eingang
26.02.2022
Impfdatum
28.01.2022
Beginn
28.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Varivax underwent a temperature excursion and was then administered to a patient; This spontaneous report has been received from a administrator concerning to a 7-years-old patient of unknown gender. The patient's concurrent condition, medical history and concomitant medications were not provided. On 28-JAN-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) (dose number, dose, route of administration and anatomical location were not provided) (lot#: U022732, expiration date: 20-JUL-2023) as prophylaxis, however, the vaccine experienced a temperature excursion (product storage error). of 12.0 Fahrenheit (F) for a total time frame of 9 hours and 38 minutes. There were previous temperature excursions: 9.7 F for 2 hours and 41 minutes, 10.8 F for 2 hours and 45 minutes, 10.6 F for 4 hours and 16 minutes, 11.1 F for 3 hours and 14 minutes, 10.9 F for 4 hours and 43 minutes, 10.8 F for 2 hours and 17 minutes, 18.3 F for 2 hours and 36 minutes, 18.7 F for 3 hours and 4 minutes, 12.4 F for 9 hours and 43 minutes, 17.4 F for 24 hours and 19.9 F for 10 hours and 57 minutes. No further information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2089713

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U022732

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
05.02.2022
Impfdatum
26.01.2022
Beginn
26.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

No additional adverse events; a dose of VARlVAX was administered to a patient today via intramuscular route versus subcutaneous route; This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 26-JAN-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) 1 dose, lot number U022732, expiration date 20-JUL-2023, intramuscular instead of subcutaneous (incorrect route of product administration) for prophylaxis. No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-